{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:11:41Z","timestamp":1784758301342,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11046-020-00471-8","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:54:59Z","timestamp":1626353699000},"page":"653-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients"],"prefix":"10.1007","volume":"185","author":[{"given":"Jin Woong","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Bean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Wook","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ja","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-5804","authenticated-orcid":false,"given":"Jong Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"471_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1\u201350.","journal-title":"Clin Infect Dis"},{"key":"471_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13613-019-0539-2","volume":"9","author":"E Ghrenassia","year":"2019","unstructured":"Ghrenassia E, Mokart D, Mayaux J, et al. Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study. Ann Intensive Care. 2019;9:62.","journal-title":"Ann Intensive Care."},{"key":"471_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s15010-018-1139-z","volume":"46","author":"J Mencarini","year":"2018","unstructured":"Mencarini J, Mantengoli E, Tofani L, et al. Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period. Infection. 2018;46:469\u201376.","journal-title":"Infection"},{"issue":"4","key":"471_CR4","first-page":"e01564","volume":"56","author":"KMT Astvad","year":"2018","unstructured":"Astvad KMT, Johansen HK, R\u00f8der BL, et al. Update from a 12-Year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern. J Clin Microbiol. 2018;56(4):e01564\u201317.","journal-title":"J Clin Microbiol."},{"key":"471_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkx047","volume":"72","author":"B Chapman","year":"2017","unstructured":"Chapman B, Slavin M, Marriott D, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother. 2017;72:1103\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"471_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2012.02.001","volume":"73","author":"D Diekema","year":"2012","unstructured":"Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 2012;73:45\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"471_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12539","volume":"20","author":"J Guinea","year":"2014","unstructured":"Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20:5\u201310.","journal-title":"Clin Microbiol Infect"},{"key":"471_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","volume":"43","author":"H Wisplinghoff","year":"2014","unstructured":"Wisplinghoff H, Ebbers J, Geurtz L, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. 2014;43:78\u201381.","journal-title":"Int J Antimicrob Agents"},{"key":"471_CR9","doi-asserted-by":"publisher","first-page":"e0165346","DOI":"10.1371\/journal.pone.0165346","volume":"11","author":"M Ishikane","year":"2016","unstructured":"Ishikane M, Hayakawa K, Kutsuna S, Takeshita N, Ohmagari N. Epidemiology of blood stream infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 years: importance of peripheral line-associated candidemia. PLoS ONE. 2016;11:e0165346.","journal-title":"PLoS ONE"},{"key":"471_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133\u201363.","journal-title":"Clin Microbiol Rev"},{"key":"471_CR11","doi-asserted-by":"publisher","first-page":"S601","DOI":"10.1093\/cid\/civ676","volume":"61","author":"TJ Walsh","year":"2015","unstructured":"Walsh TJ, Azie N, Andes DR. Development of new strategies for echinocandins: progress in translational research. Clin Infect Dis. 2015;61:S601\u20133.","journal-title":"Clin Infect Dis"},{"key":"471_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","volume":"362","author":"DW Denning","year":"2003","unstructured":"Denning DW. Echinocandin antifungal drugs. Lancet. 2003;362:1142\u201351.","journal-title":"Lancet"},{"key":"471_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/2047-783X-16-4-159","volume":"16","author":"G Kofla","year":"2011","unstructured":"Kofla G, Ruhnke M. Pharmacology and metabolism of andiulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature. Eur J Med Res. 2011;16:159\u201366.","journal-title":"Eur J Med Res"},{"key":"471_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40262-017-0578-5","volume":"57","author":"RE Wasmann","year":"2018","unstructured":"Wasmann RE, Muilwijk EW, Burger DM, Verweij PE, Knibbe CA, Br\u00fcggemann RJ. Clinical pharmacokinetics and pharmacodynamics of micafungin. Clin Pharmacokinet. 2018;57:267\u201386.","journal-title":"Clin Pharmacokinet"},{"key":"471_CR15","doi-asserted-by":"publisher","first-page":"e838","DOI":"10.1111\/j.1439-0507.2011.02045.x","volume":"54","author":"OA Cornely","year":"2011","unstructured":"Cornely OA, Marty FM, Stucker F, Pappas PG, Ullmann AJ. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease. Mycoses. 2011;54:e838\u201347.","journal-title":"Mycoses"},{"key":"471_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/imj.12110","volume":"43","author":"CF Neoh","year":"2013","unstructured":"Neoh CF, Liew D, Slavin MA, et al. Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis. Intern Med J. 2013;43:668\u201377.","journal-title":"Intern Med J"},{"key":"471_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10096-012-1754-z","volume":"32","author":"S Kohno","year":"2013","unstructured":"Kohno S, Izumikawa K, Yoshida M, et al. A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis. Eur J Clin Microbiol Infect Dis. 2013;32:387\u201397.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"471_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1086\/520980","volume":"45","author":"PG Pappas","year":"2007","unstructured":"Pappas PG, Rotstein CM, Betts RF, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007;45:883\u201393.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"471_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/myc.12746","volume":"61","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Fl\u00f6rl C, et al. EQUAL Candida Score: an ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management. Mycoses. 2018;61(5):326\u201330.","journal-title":"Mycoses"},{"key":"471_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"471_CR21","unstructured":"https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed on 10 April 2019."},{"key":"471_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","volume":"47","author":"BH Segal","year":"2008","unstructured":"Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674\u201383.","journal-title":"Clin Infect Dis"},{"key":"471_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12879-016-1825-3","volume":"16","author":"PJ van der Geest","year":"2016","unstructured":"van der Geest PJ, Hunfeld NGM, Ladage SE, Groeneveld ABJ. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study. BMC Infect Dis. 2016;16:490.","journal-title":"BMC Infect Dis"},{"key":"471_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00391-011-0280-4","volume":"46","author":"H Hof","year":"2013","unstructured":"Hof H, Mikus G. Candida infections in the elderly. Z Gerontol Geriatr. 2013;46:64\u201370.","journal-title":"Z Gerontol Geriatr"},{"key":"471_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.18632\/aging.100027","volume":"1","author":"D Aw","year":"2009","unstructured":"Aw D, Silva AB, Palmer DB. Is thymocyte development functional in the aged? Aging (Albany NY). 2009;1:146\u201353.","journal-title":"Aging (Albany NY)"},{"key":"471_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/viru.26187","volume":"5","author":"J Delaloye","year":"2014","unstructured":"Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014;5:161\u20139.","journal-title":"Virulence"},{"key":"471_CR27","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","volume":"49","author":"M Morrell","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"471_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","volume":"55","author":"AA Cleveland","year":"2012","unstructured":"Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ. Multilingualism for access, language development and language intellectualisation. Clin Infect Dis. 2012;55(10):1352\u201361.","journal-title":"Clin Infect Dis."},{"key":"471_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S118892","volume":"10","author":"EL Berkow","year":"2017","unstructured":"Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017;10:237\u201345.","journal-title":"Infect Drug Resist"},{"key":"471_CR30","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2147\/IDR.S238002","volume":"13","author":"ST Pote","year":"2020","unstructured":"Pote ST, Sonawane MS, Rahi P, Shah SR, Shouche YS, Patole MS, et al. Distribution of pathogenic yeasts in different clinical samples: their identification, antifungal susceptibility pattern, and cell invasion assays. Infect Drug Resist. 2020;13:1133\u201345.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"471_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4710-z","volume":"20","author":"NF Aldardeer","year":"2020","unstructured":"Aldardeer NF, Albar H, Al-Attas M, Eldali A, Qutub M, Hassanien A, et al. Antifungal resistance in patients with Candidaemia: a retrospective cohort study. BMC Infect Dis. 2020;20(1):1\u20137.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"471_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12879-016-1767-9","volume":"16","author":"HMS Pinhati","year":"2016","unstructured":"Pinhati HMS, Casulari LA, Souza ACR, Siqueira RA, Damasceno CMG, Colombo AL. Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit. BMC Infect Dis. 2016;16(1):4\u20139.","journal-title":"BMC Infect Dis"},{"key":"471_CR33","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3389\/fmicb.2018.02997","volume":"9","author":"DY Thomaz","year":"2018","unstructured":"Thomaz DY, De Almeida JN, Lima GME, De Oliveira Nunes M, Camargo CH, De Carvalho Grenfell R, et al. An azole-resistant Candida parapsilosis outbreak: clonal persistence in the intensive care unit of a Brazilian teaching hospital. Front Microbiol. 2018;9:2997.","journal-title":"Front Microbiol"},{"issue":"10","key":"471_CR34","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1128\/AAC.01177-15","volume":"59","author":"ACR Souza","year":"2015","unstructured":"Souza ACR, Fuchs BB, Pinhati HMS, Siqueira RA, Hagen F, Meis JF, et al. Candida parapsilosis resistance to fluconazole: Molecular mechanisms and in vivo impact in infected Galleria mellonella larvae. Antimicrob Agents Chemother. 2015;59(10):6581\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"471_CR35","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3201\/eid2409.180625","volume":"24","author":"YJ Choi","year":"2018","unstructured":"Choi YJ, Kim Y, Yong D, Byun J, Kim TS, Chang YS. Candida parapsilosis. Emerg Infect Dis. 2018;24(9):1768\u201370.","journal-title":"Emerg Infect Dis"},{"key":"471_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1592\/phco.27.3.369","volume":"27","author":"D Cappelletty","year":"2007","unstructured":"Cappelletty D, Eiselstein-McKitrick K. The echinocandins. Pharmacotherapy. 2007;27:369\u201388.","journal-title":"Pharmacotherapy"},{"key":"471_CR37","first-page":"1","volume":"7","author":"LC Hinske","year":"2012","unstructured":"Hinske LC, Weis F, Heyn J, Hinske P, Beiras-Fernandez A. The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins. Recent Pat Antiinfect Drug Discov. 2012;7:1\u20137.","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"10","key":"471_CR38","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.eimc.2015.02.021","volume":"34","author":"S Luque","year":"2016","unstructured":"Luque S, Campilo N, \u00c1lvarez-Lerma F, Ferr\u00e1ndez O, Horcajada JP, Grau S. Pharmacokinetics of micafungin in patients with pre-existing liver dysfunction: a safe option for treating invasive fungal infections. Enferm Infect Microbiol Clin. 2016;34(10):652\u20134.","journal-title":"Enferm Infect Microbiol Clin"},{"key":"471_CR39","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021506s023lbl.pdf. Accessed on 1 Jan 2020."},{"issue":"1","key":"471_CR40","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12879-018-3333-0","volume":"18","author":"F Vekeman","year":"2018","unstructured":"Vekeman F, Weiss L, Aram J, et al. Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication. BMC Infect Dis. 2018;18(1):438.","journal-title":"BMC Infect Dis"},{"key":"471_CR41","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00134-009-1511-7","volume":"35","author":"SJ Thomson","year":"2009","unstructured":"Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM. \u2018Liver function tests\u2019 on the intensive care unit: a prospective, observational study. Intensive Care Med. 2009;35:1406\u201311.","journal-title":"Intensive Care Med"},{"key":"471_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.01.029","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lu PL, Wang YL, Chen TC, Chang K, Lin SY. Usefulness of EQUAL Candida scores for predicting outcomes in patients with candidemia: a retrospective cohort study. Clin Microbiol Infect. 2020. https:\/\/doi.org\/10.1016\/j.cmi.2020.01.029.","journal-title":"Clin Microbiol Infect."},{"key":"471_CR43","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","volume":"27","author":"MC Arendrup","year":"2014","unstructured":"Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis. 2014;27:484\u201392.","journal-title":"Curr Opin Infect Dis."}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-020-00471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-020-00471-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-020-00471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:21:08Z","timestamp":1626999668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-020-00471-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1007\/s11046-020-00471-8","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"26 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}